Biosimilars for rheumatic diseases for which data have been published in peer-reviewed journals or presented at international scientific meetings
| Reference product | Biosimilar molecules |
|---|---|
| Adalimumab | ABP501 |
| BI 695501 | |
| CHS-1420 | |
| GP-2017 | |
| M923 | |
| SB5 | |
| ZRC-3197 | |
| Etanercept | CHS-0214 |
| GP2015 | |
| HD203 | |
| SB4* | |
| Infliximab | BOW015† |
| CT-P13*‡ | |
| PF-06438179 | |
| SB2 | |
| Rituximab | CT-P10 |
| GP2013 | |
| PF-05280586 |
*Approved by EMA and multiple other countries.
†Approved in India.
‡Recommended for approval by FDA.
EMA, European Medicines Agency; FDA, Food and Drug Administration.